Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €1.25 EUR
Change Today -0.014 / -1.11%
Volume 0.0
ES4 On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 9:33 AM 08/4/15 All times are local (Market data is delayed by at least 15 minutes).

escalon medical corp (ES4) Snapshot

Open
€1.29
Previous Close
€1.26
Day High
€1.29
Day Low
€1.25
52 Week High
03/20/15 - €1.50
52 Week Low
10/29/14 - €1.00
Market Cap
9.4M
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
7.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ESCALON MEDICAL CORP (ES4)

Related News

No related news articles were found.

escalon medical corp (ES4) Related Businessweek News

No Related Businessweek News Found

escalon medical corp (ES4) Details

Escalon Medical Corp. develops, manufactures, markets, and distributes ophthalmic medical devices and pharmaceuticals in the United States and Europe. It provides A-Scans, which provide information about the internal structure of the eye; B-Scans that are diagnostic tools, which supplies information to physicians where the media in the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device to provide detailed information about the anterior segment of the eye; and pachymeters, which measure the thickness of cornea. The company also offers color/fluorescein angiography digital imaging systems that are primarily used in detecting retinal problems in diabetic and elderly patients; and Ispan intraocular gases which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery, as well as a patented disposable universal gas kit that delivers the gas from the canister to the patient. In addition, it provides viscous fluid transfer systems and related disposable syringe products, which aid surgeons in the process of injecting and extracting silicone oil; light source and fiber optic products that are used by vitreoretinal surgeons during surgery; and AXIS image management system for managing images through the Web from various devices regardless of modality, manufacturer, or location. The company sells its products primarily to teaching institutions, hospitals, and eye surgery centers through internal sales employees and independent sales representatives. Escalon Medical Corp. was founded in 1987 and is based in Ardmore, Pennsylvania.

58 Employees
Last Reported Date: 09/26/14
Founded in 1987

escalon medical corp (ES4) Top Compensated Officers

Chief Executive Officer, President, General C...
Total Annual Compensation: $215.0K
Chief Financial Officer
Total Annual Compensation: $212.6K
Chief Operating Officer
Total Annual Compensation: $175.0K
Compensation as of Fiscal Year 2014.

escalon medical corp (ES4) Key Developments

Escalon Medical Corp. Announces Unaudited Consolidated Earnings Results for the Third Quarter and First Nine Months Ended March 31, 2015

Escalon Medical Corp. announced unaudited consolidated earnings results for the third quarter and first nine months ended March 31, 2015.  Consolidated product revenue increased 8.8% to $3.4 million in the third quarter of fiscal 2015 from $3.2 million in the year ago period primarily as a result of an increase in sales of the Company's Sonomed Escalon Digital Imaging and Axis image management systems as well as an increase in the sales of the Company's Ultrasound and surgical products. For the quarter ended March 31, 2015, the company reported net income of $56,542 or $0.01 per basic and diluted share and net income from continuing operations of $7,440, or $0.00 per share.  This compares to net income of $86,084 or $0.01 per basic and diluted share for the third quarter of fiscal 2014 and net income from continuing operations of $112,354, or $0.01 per share. Income from operations was $7,420 against $112,308 a year ago. For the first nine months of fiscal 2015, revenue reached $9.8 million, a 4.3% increase from $9.4 million in the year ago period and the Company reported a net loss of $476,506 or $0.06 per basic and diluted share and a net loss from continuing operations of $509,504, or $0.07 per share.  The Company had net income from continuing operations of $68,426, or $0.01 per share, for the first nine months of the prior fiscal year. Loss from operations was $509,589 against income from operations of $60,719 a year ago.

Escalon Medical Corp. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2014; Provides Financial Guidance for the Second Half of Fiscal 2015

Escalon Medical Corp. announced unaudited consolidated earnings results for the second quarter and six months ended December 31, 2014. For the second quarter of fiscal 2015, consolidated product revenue increased to $3.7 million from $3.1 million in the year ago period primarily as a result of an increase in sales of the Company's Sonomed Escalon Digital Imaging products, Axis management systems as well as an increase in the sales of the Company's Ultrasound and surgical products. For the quarter ended December 31, 2014, the company reported a net loss of $74,089 and a net loss from continuing operations of $76,748 or $0.01 per basic and diluted share. This compares to a net loss of $108,549 for the second quarter of fiscal 2014 and a net loss from continuing operations of $82,715 or $0.01 per basic and diluted share. Net revenue was $3,699,654 against $3,078,485 a year ago. Loss from operations was $76,774 against $89,306 a year ago. For the first six months of fiscal 2015, the company reported a net loss of $533,048, or $0.07 per basic and diluted share, and a net loss from continuing operations of $516,944. The net loss from continuing operations was $43,870, and net loss of $95,309 or $0.01 per basic and diluted share, for the first six months of the prior fiscal year. Net revenue was $6,329,974 against $6,208,568 a year ago. Loss from operations was $517,009 against $51,590 a year ago. The company is continuing to drive improved operational and financial results throughout the rest of fiscal 2015.

Escalon Medical Corp. Reports Consolidated Earnings Results for the First Quarter Ended September 30, 2014

Escalon Medical Corp. reported consolidated earnings results for the first quarter ended September 30, 2014. For the quarter, the company reported a net loss of $458,959 and a net loss from continuing operations of $440,196, or $0.06 per share. This compares to net income of $13,241 for the first quarter of fiscal 2014 and net income from continuing operations of $38,846. Revenues, net were $2,630,320 against $3,130,083 for the same period a year ago. Loss from operations was $440,235 against profit from operations of $37,717 for the same period a year ago. Loss from continuing operations was $440,196 or $0.06 per basic and diluted share against income from continuing operations of $38,846 or $0.00 per basic and diluted share for the same period a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ES4:GR €1.25 EUR -0.014

ES4 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ES4.
View Industry Companies
 

Industry Analysis

ES4

Industry Average

Valuation ES4 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.8x
Price/Book 3.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ESCALON MEDICAL CORP, please visit www.escalonmed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.